Document is current
Any future updates will be listed below
-
Authors
Kaufmann, Max https://orcid.org/0000-0002-1954-4425
Schaupp, Anna-Lena
Sun, Rosa https://orcid.org/0000-0002-4979-1574
Coscia, Fabian https://orcid.org/0000-0002-2244-5081
Dendrou, Calliope A.
Cortes, Adrian
Kaur, Gurman https://orcid.org/0000-0001-7722-3956
Evans, Hayley G.
Mollbrink, Annelie
Navarro, José Fernández https://orcid.org/0000-0002-4035-5258
Sonner, Jana K. https://orcid.org/0000-0002-4700-272X
Mayer, Christina
DeLuca, Gabriele C. https://orcid.org/0000-0003-0342-5197
Lundeberg, Joakim https://orcid.org/0000-0003-4313-1601
Matthews, Paul M. https://orcid.org/0000-0002-1619-8328
Attfield, Kathrine E.
Friese, Manuel A. https://orcid.org/0000-0001-6380-2420
Mann, Matthias https://orcid.org/0000-0003-1292-4799
Fugger, Lars https://orcid.org/0000-0003-2883-3226
- License Information
-
More Information
Article History
Received: 7 January 2022
Accepted: 16 May 2022
First Online: 20 June 2022
Competing interests
: G.C.D. has received research funding from Merck Serono, travel expenses from Bayer Schering, Biogen Idec, Genzyme, Merck Serono, Novartis and honoraria as an invited speaker/faculty/advisor for Novartis and Roche. J.L. and A.M. are scientific consultants for 10X Genomics. P.M.M. has received consultancy fees from Roche, Adelphi Communications, Celgene, Neurodiem and Medscape, honoraria or speakers’ fees from Novartis and Biogen and has received research or educational funds from Biogen, Novartis and GlaxoSmithKline. The remaining authors declare no competing interests.
